James Cullem
Plus aucun poste en cours
Fortune : - $ au 30/04/2024
Historique de carrière de James Cullem
Anciens postes connus de James Cullem
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Director/Board Member | 01/07/2022 | 08/12/2023 |
| Chief Executive Officer | 01/06/2022 | 08/12/2023 | |
| Corporate Officer/Principal | 01/10/2019 | 01/06/2022 | |
| ALLARITY THERAPEUTICS, INC. | Director/Board Member | 07/07/2022 | 08/12/2023 |
| Chief Executive Officer | 29/06/2022 | 08/12/2023 | |
| Corporate Officer/Principal | 06/04/2021 | 29/06/2022 | |
Oncology Venture Sweden AB
 Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Corporate Officer/Principal | 01/01/2015 | - |
Statistiques
Internationale
| Danemark | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorielle
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Bourse
- Insiders
- James Cullem
- Expérience
